MedPath

Autologous Bone Marrow Stem Cell Therapy Combined With Psychological Therapy and Rehabilitation for Autism

Phase 2
Completed
Conditions
Stem Cell Transplantation
Interventions
Biological: Stem cell transplantation
Behavioral: Psychological therapy and Rehabilitation
Registration Number
NCT03225651
Lead Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Brief Summary

The aim of this study was to evaluate the safety and effectiveness of autologous bone marrow mononuclear stem cells combined with Psychological Therapy and Rehabilitation for Autism children

Detailed Description

The aim of this study was to evaluate the safety and effectiveness of autologous bone marrow mononuclear stem cells combined with Psychological Therapy and Rehabilitation in the management of autism of 60 patients at Vinmec Research Institute of Stem Cell and Gene Technology Hanoi, Vietnam from January 2017 to December 2018

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Confirmed diagnosis of autism according to the Diagnostic and Statistical Manual-V diagnostic criteria for autistic disorder
Exclusion Criteria
  • Epilepsy
  • Hydrocephalus with ventricular drain
  • Coagulation disorders
  • Allergy to anesthetic agents
  • Severe health conditions such as cancer, failure of heart, lung, liver or kidney
  • Active infections
  • Severe psychiatric disorders
  • Rett syndrome
  • Fragile X syndrome

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Psychological therapy and rehabilitationPsychological therapy and RehabilitationPsychological therapy Rehabilitation in 3 months
Psychological therapy and rehabilitationStem cell transplantationPsychological therapy Rehabilitation in 3 months
Stem cell transplantationStem cell transplantationStem cell transplantation 2 intrathecal administrations of autologous bone marrow mononuclear cells at baseline and 6 months afterward
Stem cell transplantationPsychological therapy and RehabilitationStem cell transplantation 2 intrathecal administrations of autologous bone marrow mononuclear cells at baseline and 6 months afterward
Primary Outcome Measures
NameTimeMethod
Assess the change in autism level by using tools6 months and 12 months after transplantation

using total score of childhood autism rating scale, autism diagnostic observation schedule second edition, DENVER II, Indian Scale for assessment of Autism

Evaluate the safety of therapy by record number of adverse eventsThrough study completion, an average of 12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Vinmec Research Institute of Stem Cell and Gene Technology

🇻🇳

Hanoi, Vietnam

© Copyright 2025. All Rights Reserved by MedPath